Revenue and gross profit: No revenue recognized in Q4 2024 (blank-check SPAC profile). QoQ and YoY revenue comparisons are not applicable.
Operating income: -$479,563 for Q4 2024; QoQ change -130.58% (significant deterioration vs prior quarter); YoY data not available due to SPAC structure.
Net income: -$106,818 for Q4 2024; QoQ change -153.28%; YoY change +82.74% (noting that prior-year results for a SPAC blank-check period may reflect different baseline conditions).
EPS: -$0.019 for Q4 2024; QoQ change -163.33%; YoY change +89.44%.
EBITDA/EBITDA margin: -$479,563 (EBITDA) with operating income of -$479,563; EBITDA is negative due to the same operating cost structure coupled with offsetting non-operating income.
Other income/expenses: Total other income and expenses of $372,745 in Q4 2024, contributing to a pre-tax result of -$106,818 and net income of -$106,818.
Cash flow and liquidity: Net cash provided by operating activities -$211,185; change in working capital +$268,378; accounts payable +$263,991; other working capital +$4,387; other non-cash items -$372,745.
Investing activities: Net cash used in investing activities -$154,094 (primarily non-operational capex/spin-off related items).
Financing activities: Net cash provided by financing activities +$350,094 (includes debt-related activity and equity actions; specifics show debt repayment of -$1,535,304 and a common stock repurchase of -$4,872,513 with other financing activity totaling -$2,987,115).
Net change in cash: -$15,185; cash at end of period: $25,348; cash at beginning of period: $40,533.
Balance sheet: Total assets $31,747,147; cash and cash equivalents $25,348; total current assets $82,134; total non-current assets $31,665,013; total liabilities $9,389,924; total current liabilities $5,364,924; total non-current liabilities $4,025,000; stockholders’ equity $22,357,223.
Liquidity and leverage: Current ratio 0.0153; quick ratio 0.0153; cash ratio 0.0047; total debt $3,813,371; net debt $3,788,023; debt ratio 0.120; debt to equity 0.171.
Valuation metrics: Price to book value 3.37; price to earnings -176.15 (negative earnings context); price to sales 0; price to free cash flow negative; enterprise value multiple -164.84; price fair value around 3.37 (reflecting SPAC-specific valuation mechanics).